Inhibrx Biosciences, Inc.

Direct answer

Inhibrx Biosciences, Inc. is publicly traded on NASDAQ under the ticker INBX.

Inhibrx Biosciences, Inc. is a biopharmaceutical company currently in its clinical development phase, focused on creating and advancing biological treatments for patients afflicted with severe, life-threatening medical conditions. Its pipeline features several investigational therapies, notably INBRX-109. This tetravalent therapeutic candidate, which targets death-receptor 5, is undergoing Phase 2 clinical trials...

Can you invest in Inhibrx Biosciences, Inc.?

Yes. Inhibrx Biosciences, Inc. trades publicly on NASDAQ as INBX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Inhibrx Biosciences, Inc.

Detailed equity research is provided by MarketSnap.